David Toung
Stock Analyst at Argus Research
(4.25)
# 486
Out of 4,740 analysts
116
Total ratings
63.74%
Success rate
10.79%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie | Upgrades: Buy | n/a | $169.20 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $128.75 | -2.91% | 9 | Sep 11, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $570 → $600 | $519.72 | +15.45% | 7 | Jul 17, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Hold | n/a | $168.22 | - | 5 | Jun 28, 2024 | |
| AMGN Amgen | Maintains: Buy | $300 → $340 | $273.44 | +24.34% | 10 | Jun 27, 2024 | |
| MCK McKesson | Maintains: Buy | $570 → $670 | $584.38 | +14.65% | 6 | Jun 24, 2024 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Buy | $150 | $109.72 | +36.71% | 7 | May 21, 2024 | |
| LLY Eli Lilly | Maintains: Buy | $770 → $840 | $753.98 | +11.41% | 3 | May 14, 2024 | |
| HOLX Hologic | Maintains: Buy | $89 → $95 | $71.19 | +33.45% | 1 | May 9, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $80 → $110 | $87.33 | +25.96% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $242.45 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $26.01 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $284.92 | - | 8 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $540 → $550 | $574.59 | -4.28% | 6 | Nov 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $24.85 | - | 1 | Jun 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $390.49 | -20.61% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $319.51 | -2.98% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $610.45 | -47.58% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $117.78 | +14.62% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $93.04 | -19.39% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $57.09 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $95.68 | +14.97% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $87.84 | +87.84% | 6 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.88 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $78.71 | +55.63% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $68.20 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $98.17 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $145.27 | +6.70% | 4 | Mar 27, 2020 |
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $169.20
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $128.75
Upside: -2.91%
UnitedHealth Group
Jul 17, 2024
Maintains: Buy
Price Target: $570 → $600
Current: $519.72
Upside: +15.45%
Charles River Laboratories International
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $168.22
Upside: -
Amgen
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $273.44
Upside: +24.34%
McKesson
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $584.38
Upside: +14.65%
Zimmer Biomet Holdings
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $109.72
Upside: +36.71%
Eli Lilly
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $753.98
Upside: +11.41%
Hologic
May 9, 2024
Maintains: Buy
Price Target: $89 → $95
Current: $71.19
Upside: +33.45%
GE HealthCare Technologies
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $87.33
Upside: +25.96%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $242.45
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $26.01
Upside: -
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $284.92
Upside: -
Nov 6, 2023
Maintains: Buy
Price Target: $540 → $550
Current: $574.59
Upside: -4.28%
Jun 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $24.85
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $390.49
Upside: -20.61%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $319.51
Upside: -2.98%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $610.45
Upside: -47.58%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $117.78
Upside: +14.62%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $93.04
Upside: -19.39%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $57.09
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $95.68
Upside: +14.97%
Aug 27, 2021
Maintains: Buy
Price Target: $150 → $165
Current: $87.84
Upside: +87.84%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $9.88
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $78.71
Upside: +55.63%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $68.20
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $98.17
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $145.27
Upside: +6.70%